References
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi:10.1056/NEJMoa1008232.
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510.
- Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–1798. doi:10.1056/NEJMoa1400590.
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616.
- Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225. doi:10.1016/S0140-6736(16)30073-3.
- Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7(8):898–904. doi:10.1016/j.jcin.2014.04.005.
- Binder RK, Stortecky S, Heg D, et al. Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: an observational cohort study of Sapien 3 versus Sapien XT transcatheter heart valves. Circ Cardiovasc Interv. 2015;8(10):e002653. doi:10.1161/CIRCINTERVENTIONS.115.002653.
- Husser O, Pellegrini C, Kessler T, et al. Outcomes after transcatheter aortic valve replacement using a novel balloon-expandable transcatheter heart valve: a single-center experience. JACC Cardiovasc Interv. 2015;8(14):1809–1816. doi:10.1016/j.jcin.2015.08.014.
- Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imag. 2013;6(2):249–262. doi:10.1016/j.jcmg.2012.12.005.
- Shivaraju A, Kodali S, Thilo C, et al. Overexpansion of the SAPIEN 3 transcatheter heart valve: a feasibility study. JACC Cardiovasc Interv. 2015;8(15):2041–2043. doi:10.1016/j.jcin.2015.10.006.
- Shivaraju A, Thilo C, Ott I, et al. Tools and techniques – Clinical: fluoroscopic balloon sizing of the aortic annulus before transcatheter aortic valve replacement (TAVR) – follow the “right cusp rule”. EuroIntervention. 2015;11(7):840–842. doi:10.4244/EIJV11I7A170.
- Mayr NP, Hapfelmeier A, Martin K, et al. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcomedagger. Br J Anaesth. 2016;116(1):90–99. doi:10.1093/bja/aev294.
- Kasel AM, Cassese S, Leber AW, Von Scheidt W, Kastrati A. Fluoroscopy-guided aortic root imaging for TAVR: “follow the right cusp” rule. JACC Cardiovasc Imag. 2013;6(2):274–275. doi:10.1016/j.jcmg.2012.06.014.
- Shivaraju A, Ott I, Cassese S, et al. Fluoroscopic calcification-guided optimal deployment projection during transcatheter aortic valve replacement – “The eye of the pigtail.” (Follow Right Cusp rule–Part II). Catheter Cardiovasc Interv. 2016;87(5):996–998. doi:10.1002/ccd.25929.
- Ott I, Shivaraju A, Schaffer NR, et al. Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI). EuroIntervention. 2017; Jaa-161 2017, doi. 4244/EIJ-D-16-01036
- Kasel AM, Shivaraju A, Von Scheidt W, Kastrati A, Thilo C. Anatomic guided crossing of a stenotic aortic valve under fluoroscopy: “right cusp rule, part III”. JACC Cardiovasc Interv. 2015;8(1Pt A):119–120. doi:10.1016/j.jcin.2014.10.009.
- Kasel AM, Shivaraju A, Schneider S, et al. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance. J Invasive Cardiol. 2014;26(9):451–461.
- Kronzon I, Jelnin V, Ruiz CE, et al. Optimal imaging for guiding TAVR: transesophageal or transthoracic echocardiography, or just fluoroscopy? JACC Cardiovasc Imag. 2015;8(3):361–370. doi:10.1016/j.jcmg.2015.01.003.
- Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–1454. doi:10.1016/j.jacc.2012.09.001.
- Tarantini G, Mojoli M, Purita P, et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention. 2015;11(3):343–350. doi:10.4244/EIJY14M11_06.
- De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the Pacemaker rate after transition from edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9(8):805–813. doi:10.1016/j.jcin.2015.12.023.
- Schwerg M, Fulde F, Dreger H, Poller WC, Stangl K, Laule M. Optimized implantation height of the Edwards SAPIEN 3 valve to minimize pacemaker implantation after TAVI. J Interv Cardiol. 2016;29(4):370–374. doi:10.1111/joic.12302.
- Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65(20):2173–2180. doi:10.1016/j.jacc.2015.03.034.
- Gaede L, Kim WK, Blumenstein J, et al. Temporal trends in transcatheter and surgical aortic valve replacement: an analysis of aortic valve replacements in Germany during 2012–2014. Herz. 2017; May;42(3):316–324. doi:10.1007/s00059-016-4461-1. Epub 2016 Aug 5.
- Petronio AS, Capranzano P, Barbato E, et al. Current status of transcatheter valve therapy in Europe: results from an EAPCI survey. EuroIntervention. 2016;12(7):890–895. doi:10.4244/EIJY16M06_01.
- Jerez-Valero M, Urena M, Webb JG, et al. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation. JACC Cardiovasc Interv. 2014;7(9):1022–1032. doi:10.1016/j.jcin.2014.04.012.
- Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5(5):461–467. doi:10.1016/j.jcin.2012.01.018.
- Dvir D, Jhaveri R, Pichard AD. The minimalist approach for transcatheter aortic valve replacement in high-risk patients. JACC Cardiovasc Interv. 2012;5(5):468–469. doi:10.1016/j.jcin.2012.01.019.
- Barbanti M, Capranzano P, Ohno Y, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101(18):1485–1490. doi:10.1136/heartjnl-2014-307351.
- Durand E, Eltchaninoff H, Canville A, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol. 2015;115(8):1116–1122. doi:10.1016/j.amjcard.2015.01.546.
- O’Connor ED, Walsham J. Should we mobilise critically ill patients? A review. Crit Care Resusc. 2009;11(4):290–300.
- Coeytaux RR, Williams JW Jr., Gray RN, Wang A. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann Intern Med. 2010;153(5):314–324. doi:10.7326/0003-4819-153-5-201009070-00267.
- Frohlich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR) – systematic review and meta-analysis. BMC Med. 2014;12:41. doi:10.1186/1741-7015-12-41.